Literature DB >> 7904023

Lewy bodies and response to tacrine in Alzheimer's disease.

R Levy, S Eagger, M Griffiths, E Perry, M Honavar, A Dean, P Lantos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7904023     DOI： 10.1016/s0140-6736(94)90966-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  16 in total

Review 1.  Functional imaging of the brain in the evaluation of drug response and its application to the study of aging.

Authors:  C A Bryant; S H Jackson
Journal:  Drugs Aging       Date:  1998-09       Impact factor: 3.923

2.  Cholinesterase inhibition in Parkinson's disease.

Authors:  M Hutchinson; E Fazzini
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-09       Impact factor: 10.154

Review 3.  The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems.

Authors:  A D Lawrence; B J Sahakian
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

4.  Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies.

Authors:  Jonathan Graff-Radford; Bradley F Boeve; Otto Pedraza; Tanis J Ferman; Scott Przybelski; Timothy G Lesnick; Prashanthi Vemuri; Matthew L Senjem; Glenn E Smith; David S Knopman; Val Lowe; Clifford R Jack; Ronald C Petersen; Kejal Kantarci
Journal:  Brain       Date:  2012-07-18       Impact factor: 13.501

Review 5.  Dementia with Lewy bodies: clinical features and treatment.

Authors:  S Campbell; S Stephens; C Ballard
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

6.  Tacrine and lecithin in Alzheimer's disease. Patient heterogeneity explains varied response.

Authors:  R Levy
Journal:  BMJ       Date:  1994-06-04

7.  The new Qualitative Scoring MMSE Pentagon Test (QSPT) as a valid screening tool between autopsy-confirmed dementia with Lewy bodies and Alzheimer's disease.

Authors:  Micaela Mitolo; David P Salmon; Simona Gardini; Douglas Galasko; Enzo Grossi; Paolo Caffarra
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

8.  The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design.

Authors:  L Bonanni; A Cagnin; F Agosta; C Babiloni; B Borroni; M Bozzali; A C Bruni; M Filippi; D Galimberti; R Monastero; C Muscio; L Parnetti; D Perani; L Serra; V Silani; P Tiraboschi; A Padovani
Journal:  Neurol Sci       Date:  2016-09-13       Impact factor: 3.307

9.  Atrophy of the cholinergic basal forebrain in dementia with Lewy bodies and Alzheimer's disease dementia.

Authors:  Michel J Grothe; Christina Schuster; Florian Bauer; Helmut Heinsen; Johannes Prudlo; Stefan J Teipel
Journal:  J Neurol       Date:  2014-07-25       Impact factor: 4.849

Review 10.  Benefit-risk considerations in the treatment of dementia with Lewy bodies.

Authors:  Margaret M Swanberg; Jeffrey L Cummings
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.